Texas Children’s provides new breakthrough treatment for patient with AADC deficiency [caption id="" align="alignnone" width="700"] Texas Children's neurosurgeon Dr. Daniel Curry leads first-ever FDA-approved gene therapy treatment for AADC deficiency. ©Texas Children's Hospital[/caption] On August 19, 2025, Texas Children's, a non-profit healthcare organization, has announced that a three-year-old girl has…..